Which treatment saves more lives from lung clots? major study launches
NCT ID NCT07603700
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 1,300 people with moderate-risk pulmonary embolism (blood clots in the lungs) to compare three treatments: blood thinners, clot-busting drugs, and mechanical clot removal. Researchers will track deaths, heart recovery, bleeding risks, and quality of life over 90 days. The goal is to find the safest and most effective approach for each patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new exercise plan aims to get pulmonary embolism survivors back on their feet
- Could tailored blood thinner dosing prevent strokes in chinese patients?
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- Could a simple aspirin pill replace daily shots to prevent postpartum blood clots?
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- Massive chest pain registry reveals gaps between guidelines and real-world care in china